Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+25.4%
5Y CAGR+32.0%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+25.4%/yr
vs +54.2%/yr prior
5Y CAGR
+32.0%/yr
Recent deceleration
Acceleration
-28.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$461.64M+25.8%
2024$367.09M+36.6%
2023$268.76M+14.8%
2022$234.19M+44.2%
2021$162.39M+41.2%
2020$115.02M-23.5%
2019$150.32M+262.8%
2018$41.44M-